DUZALLO
AstraZeneca AB
The mark consists of two interlocking rhombi with rounded corners positioned to the left of and level with the term "DUZALLO".
Mark For: DUZALLO® trademark registration is intended to cover the category of
>Color is not claimed as a feature of the mark. The mark consists of two interlocking rhombi with rounded corners positioned to the left of and level with the term "DUZALLO".
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88017647 |
| Registration Number | 5803545 |
| Mark Literal Elements | DUZALLO |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-07-16 |
| Basis | 1(a) 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Wm. Charles Saunders |
| Attorney Docket Number | 103588/US |
| Law Office Assigned | L80 |
| Employee Name | CALLAGHAN, BRIAN P |
Timeline
| 2017-10-06 | Date of First Use |
| 2017-10-06 | Date of Use In Commerce |
| 2018-06-27 | Application Filed |
| 2018-08-06 | Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED |
| 2018-08-06 | Status: Live/Pending |
| 2019-02-11 | Transaction Date |
| 2019-04-30 | Published |
| 2019-04-30 | Published for Opposition |
| 2019-07-16 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-07-16 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2019-07-16 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  AstraZeneca AB |
| Address | Vastra Malarehamnen 9 Södertälje SWEDEN SE-15185 |
| Legal Entity Type | Aktiebolag (ab) |
| Legal Entity State | SWEDEN |
Documents
 Drawing | JPEG | 2018-06-27 |
| Specimen | JPEG | 2018-06-27 |
 TEAS RF New Application | MULTI | 2018-06-27 |
| Design Search Code Corr Project | APPLICATION/XML | 2018-07-03 |
| Suspension Letter | XML | 2018-08-06 |
| XSearch Search Summary | XML | 2018-08-06 |
| Change of Address | XML | 2019-02-08 |
| Suspension Inquiry | XML | 2019-03-03 |
| TEAS Response to Suspension Inquiry | MULTI | 2019-03-15 |
| Amendment and Mail Process Complete | MULTI | 2019-03-19 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-03-19 |
| Notice of Publication | XML | 2019-04-10 |
| Notification Of Notice of Publication | XML | 2019-04-10 |
| OG Publication Confirmation | XML | 2019-04-30 |
| Registration Certificate | 2019-07-16 | |
| TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-08-08 |
Design Search Codes
| 260713 | Diamonds, exactly two diamonds; Two diamonds |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for use in the treatment of hyperuricemia associated with gout. FIRST USE: 20171006. FIRST USE IN COMMERCE: 20171006
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for use in the treatment of hyperuricemia associated with gout |
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-08-08 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-08-08 | |
| REGISTERED-PRINCIPAL REGISTER | 2019-07-16 | |
| PUBLISHED FOR OPPOSITION | 2019-04-30 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-04-30 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-04-10 | |
| DATA MODIFICATION COMPLETED | 2019-03-18 | 76568 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-03-18 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-03-16 | 76568 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-03-16 | 76568 |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-03-15 | |
| SUSPENSION INQUIRY WRITTEN | 2019-03-03 | 83694 |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-03-03 | |
| INQUIRY TO SUSPENSION E-MAILED | 2019-03-03 | |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-03-01 | 76568 |
| ASSIGNED TO LIE | 2019-02-28 | 76568 |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-02-08 | |
| SUSPENSION LETTER WRITTEN | 2018-08-06 | 83694 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-08-06 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2018-08-06 | 6332 |
| ASSIGNED TO EXAMINER | 2018-08-06 | 83694 |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-07-03 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-07-02 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-06-30 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DUZALLO 88017647 not registered Live/Pending |
AstraZeneca AB 2018-06-27 |
 DUZALLO 86919928 5239241 Live/Registered |
AstraZeneca AB 2016-02-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 